Rayence Co

Rayence Co Debt / Assets

The Debt-to-Assets Ratio of Rayence Co (228850.KQ) as of Oct 23, 2026 is 0.01. In the previous year, Debt-to-Assets Ratio was 0.01 — a change of 20.16% (higher).

Debt / Assets

0.01

YoY

20.16%

Last updated:

Debt-to-Assets Ratio of Rayence Co is 2024 0.01 . Debt-to-Assets Ratio of Rayence Co was 2023 0.01 . It decreases by 20.16% higher compared to the previous year.

The Rayence Co Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2017
0.02 KRW
Jan 1, 2018
0.01 KRW
Jan 1, 2019
0.03 KRW
Jan 1, 2020
0.03 KRW
Jan 1, 2021
0.02 KRW
Jan 1, 2022
0.01 KRW
Jan 1, 2023
0.01 KRW
Jan 1, 2024
0.01 KRW
The Rayence Co Debt / Assets history
YEARDebt / AssetsYoY
0.01+20.16%
0.01+12.80%
0.01-51.87%
0.02-17.92%
0.03+2.50%
0.03+214.86%
0.01-62.27%
0.02-24.50%
0.03-84.24%
0.18-19.02%
0.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rayence Co Stock analysis

What does Rayence Co do? Rayence Co., Ltd. generates revenue through the manufacturing and sale of x-ray detectors, including TFT and CMOS detectors under brand names such as 1012WCA, 17SCC/SGC, 1215CF, 1501CF, and 0712CF. The company also produces intra oral sensors branded as Ez1.0 and Ez1.5, along with mammography machines under the 1724CM and 2434CM series. These products are distributed to both domestic and international markets, serving healthcare providers and medical facilities that require diagnostic imaging equipment. The primary customers for Rayence's detectors and sensors are hospitals, clinics, and medical imaging centers seeking advanced x-ray technology. The firm's product portfolio targets the medical imaging segment, focusing on applications such as dental diagnostics with intra oral sensors and radiological imaging with mammography machines. Revenue streams are derived from direct sales of these branded products to healthcare institutions across multiple regions. Rayence's business model centers on selling specialized medical imaging equipment under its own brand names, with no mention of third-party partnerships or additional services. The company's revenue is directly tied to the purchase of its branded x-ray detectors, intra oral sensors, and mammography machines by healthcare providers who require high-quality diagnostic tools for patient care. Rayence Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rayence Co stock

Debt-to-Assets Ratio of Rayence Co is 0.01 in 2024.

Debt-to-Assets Ratio of Rayence Co changed from 0.01 to 0.01, representing a 20.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Rayence Co since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Rayence Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Rayence Co

All Key Metrics — Rayence Co